Your session is about to expire
← Back to Search
Pathways Intervention for Autism
Study Summary
This trial tests if Pathways is better than PEI for helping autistic children develop social skills and reducing parental stress. Parents enrolled will receive one of two treatments and assessments of their child at intervals.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You do not meet the requirements to participate in the study.My primary home language is either English or Spanish.I am a caregiver with a child aged 12-42 months.You have been diagnosed with autism or there is a suspicion that you have it.You have been diagnosed with or are suspected of having autism.You are a student at the University of Texas at Dallas.My child is between 1 and 3.5 years old.I do not have any known neurological or genetic disorders.I do not have any known neurological or genetic disorders.
- Group 1: Pathways Intervention
- Group 2: Parent Education Intervention (PEI)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there still opportunities for patients to participate in this research?
"The data hosted on clinicaltrials.gov affirms that this investigation is still looking for potential participants. It was created on October 27th 2022 and updated lastly on November 11th 2022."
What are the goals of this research endeavor?
"The primary goal of this clinical trial, tracked over 36 weeks with assessments conducted every 12 weeks, is to determine the impact on intentional communication. Additionally, changes in child adaptive functioning (as measured by Vineland II), cognitive skills (assessed via Bayley-4) and motor skills (also assessed via Bayley-4) will be monitored as secondary objectives."
Is this clinical trial catering to geriatric individuals?
"As specified by the trial's eligibility criteria, individuals aged between 12 Months and 42 Months are able to participate. Out of 271 trials, 229 target minors while 42 focus on elderly patients."
Who is able to take part in the current clinical experiment?
"Eligibility for this trial requires an autism spectrum disorder diagnosis and the patient to be between 12 months old and 42 months old. A total of 150 participants are needed to complete the study."
What is the scope of patients included in this trial?
"Affirmative. According to clinicaltrials.gov, this medical trial is actively recruiting patients since its inception on October 27th 2022 and subsequent update on November 11th 2022. This specific investigation requires 150 participants at a single site."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
What site did they apply to?
How responsive is this trial?
Most responsive sites:
- The University of Texas/Callier Center for Communication Disorders: < 24 hours
Average response time
- < 1 Day
Typically responds via
Share this study with friends
Copy Link
Messenger